News | May 07, 2026
Neuland Labs and LIR Life partner on next-gen transdermal GLP-1 obesity therapy platform
LIR Life is working on a patch-based, transdermal delivery system for GLP-1 therapies targeting obesity
LIR Life is working on a patch-based, transdermal delivery system for GLP-1 therapies targeting obesity
Bolli will lead worldwide business development for the company’s Contract Development and Manufacturing Organisation (CDMO) services
18-year veteran Saharsh will position the CDMO as a premier global API process development and commercial manufacturing specialist
The first of four planned modules at the new plant is expected to come online by summer 2026
The revenues this quarter are in line with the outlook we envisaged for the year
Granules India receives 1 observation from USFDA for Chantilly facility
The company has posted net profit of Rs. 260.10 crores for the Financial Year ended March 31, 2025
The FDA issued Form 483 with one observation related to building and facility management
Prior to joining Neuland, Deshmukh held several key positions at Cipla
The company plans to fund this Capex through debt and internal accruals and expects the project to be completed by FY27
Subscribe To Our Newsletter & Stay Updated
